Related Experiment Video
Updated: May 25, 2025

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
[Rare forms of dedifferentiated chondrosarcomas: About 3 cases]
Lola Beele1, Elodie Miquelestorena-Standley2, Gonzague De Pinieux1
1Service anatomie et cytologie pathologiques, CHU Trousseau, avenue de la République, 37170 Chambray-lès-Tours, France.
None:
Conventional chondrosarcoma is the most common primary malignant bone tumor in adults. Dedifferentiated chondrosarcomas represent 10 to 15% of conventional chondrosarcomas and constitute a high-grade subtype with a poor prognosis, with a 5-year survival rate of 24%. These tumors are characterized by a mutation in one of the isocitrate dehydrogenase (IDH) 1 or 2 genes in 70% of cases. Histological diagnosis requires a biphasic morphology combining a low-grade conventional chondrosarcoma component with a high-grade non-cartilaginous sarcomatoid component. In the literature, this dedifferentiated component most often corresponds to an osteosarcoma or an undifferentiated sarcomatous component. This article describes three cases of dedifferentiated chondrosarcomas: two with bone localization and one with laryngeal cartilaginous localization presenting a rare dedifferentiation component, either epithelial or rhabdomyosarcomatous, which may pose a diagnostic challenge, particularly in micro-biopsy samples. The mechanism of dedifferentiation is still poorly understood, and the origin of the dedifferentiated component remains controversial.

